Epigenomics of Breast Cancer

Our research focuses on understanding how breast cancer cells respond and adapt to treatment, with particular emphasis on the role of epigenetic and transcriptional regulation in endocrine resistance. We use large-scale multi-omics data, including single-cell analyses, to identify regulatory mechanisms that enable cancer cells to survive treatment and develop resistance. By combining computational approaches with functional experiments, including CRISPR-based epigenetic editing, gene perturbation, and in vitro drug testing, we investigate the causal roles of regulatory mechanisms in treatment response and resistance. Ultimately, our goal is to uncover new therapeutic vulnerabilities that can be exploited to overcome resistance and identify biomarkers of treatment response.

Contact information

thofle@ous-hf.no

Key publications